CAS: 4923-87-9; 5-Bromobenzothiophene

该化合物是一种有机化合物,其特点是其引信芳香系统,其中包括一个硫苯环和在苯并[b]thiophene结构的5个位置上的溴替代物.该化合物通常展示一个板状结构,有助于其产生欧元堆叠相互作用的潜力,从而影响其电子特性.它一般在水中无法溶解,但可能会溶解于二氯甲烷或乙醇等有机溶剂中.其存在于二氯甲烷或乙醇等有机溶剂中,溴原子会增强它的再活性,使其在各种有机合成反应中成为有用的中间体,包括交叉反应和电动替代.此外,5-Bromobenzo[b]thiophene可以作为合成更复杂的有机材料的建筑块块,包括有机电子和光化应用中所使用的材料.其独特的结构和特性使得它既具有学术研究意义,又具有工业用途,特别是在材料科学和有机化学领域.在处理这一化合物时,应当作为安全防范措施,因为有许多有机生物质.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号96804-05-6 1-溴-4-[(2,2-二乙氧... | CAS号118780-12-4 (4-溴苯)(2,2-二甲氧基乙基)硫 | CAS号106-53-6 4-溴苯硫酚 | CAS号66282-89-1 5-bromo-benzo[b... | CAS号7312-10-9 5-溴-1-苯并噻吩-2-羧酸 | CAS号108-86-1 溴苯 | CAS号98-58-8 对溴苯磺酰氯 | CAS号3406-76-6 Acetic acid,2-[... | CAS号501945-71-7 2-(1-苯并噻吩-5-基)-... | CAS号20532-30-3 5-甲氧基苯并噻吩 | CAS号20532-28-9 5-氨基苯并噻吩 | CAS号2060-63-1 1-苯并噻吩-5-腈 | CAS号2060-64-2 1-苯并噻吩-5-羧酸 | CAS号96803-30-4 2-(1-苯并噻吩-5-基)乙-1-醇 | CAS号7312-24-5 5-溴苯并[B]噻吩-3-甲酸 | CAS号1423-63-8 1-(5-溴-1-苯并噻吩-3-基)乙酮 | CAS号306762-46-9 5-溴-2-碘苯并[b]噻吩 | CAS号16296-72-3 5-溴苯并[b]噻吩-3-甲醛

合成工艺路线路线简述

  • 合成目标产物 5-Bromobenzo[b]Thiophene 主要起始原料 Acetaldehyde, 2-[(4-Bromophenyl)Thio]-
  • (文献来源)合成步骤主要原料 Acetaldehyde, 2-[(4-Bromophenyl)Thio]-
5-溴-2-氟苯甲醛置于1,8-二氮杂双环[5.4.0]十一碳-7-烯,三乙胺,Potassium Hydroxide体系中,用 乙醇,N,N-二甲基乙酰胺,水,二甲基亚砜 作为反应溶剂,化学反应 7.0H,反应生成 5-溴苯并[b]噻吩
参考文献:Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines And Tetraoxanes Potential Two-Stage Antimalarials
标题:Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines And Tetraoxanes Potential Two-Stage Antimalarials
摘要:The Syntheses And Antiplasmodial Activities Of Various Substituted Aminoquinolines Coupled To An Adamantane Carrier Are Described. The Compounds Exhibited Pronounced In Vitro And In Vivo Activity Against Plasmodium Berghei In The Thompson Test. Tethering A Fluorine Atom To The Aminoquinoline C(3) Position Afforded Fluoroaminoquinolines That Act As Intrahepatocytic Parasite Inhibitors,With Compound 25 Having An Ic50 = 0.31 Mu M And Reducing The Liver Load In Mice By Up To 92% At 80 Mg/kg Dose. Screening Our Peroxides As Inhibitors Of Liver Stage Infection Revealed That The Tetraoxane Pharmacophore Itself Is Also An Excellent Liver Stage P. Berghei Inhibitor (78: Ic50 = 0.33 Mu M). Up To 91% Reduction Of The Parasite Liver Load In Mice Was Achieved At 100 Mg/kg. Examination Of Tetraoxane 78 Against The Transgenic 3D7 Strain Expressing Luciferase Under A Gametocyte-Specific Promoter Revealed Its Activity Against Stage Iv-V Plasmodium Falciparum Gametocytes (Ic50 = 1.16 +/-0.37 Mu M). To The Best Of Our Knowledge,Compounds 25 And 78 Are The First Examples Of Either An 4-Aminoquinoline Or A Tetraoxane Liver Stage Inhibitors.
DOI:10.1021/acs.Jmedchem.5B01374

专利信息


专利号:CN-108373416-B
优先权日:2018-04-28
标 题 :A kind of method of photo/nickel synergistic catalysis synthesis of diarylamine

专利号:US-9351954-B2
优先权日:2009-12-04
标 题:Multicyclic compounds and methods of use thereof
发明人:SHAO LIMING; CAMPBELL JOHN EMMERSON; HEWITT MICHAEL CHARLES; CAMPBELL UNA; HANANIA TALEEN G
权利人:SUNOVION PHARMACEUTICALS INC; PGI DRUG DISCOVERY LLC
摘要:Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. For example, disclosed herein are compounds having formula (IIa) shown below, or a pharmaceutically acceptable salt or stereoisomer thereof, wherein the variables are defined herein. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.

专利号:CN-117466744-A
优先权日:2023-11-02
标 题:A method for photochemical iron-catalyzed synthesis of aromatic amine compounds

专利号:US-2007275968-A1
优先权日:2004-09-07
标 题 :Substituted Biphenyl Derivative
发明人:KURATA HITOSHI; NISHIMATA TOYOKI; WATANABE YUKIKO; EBISAWA MASAYUKI; FUJIMOTO TEPPEI; KOBAYASHI HIDEKI
权利人:KURATA HITOSHI; NISHIMATA TOYOKI; WATANABE YUKIKO; EBISAWA MASAYUKI; FUJIMOTO TEPPEI; KOBAYASHI HIDEKI
摘要:The present invention relates to a biaryl derivative or a pharmacologically acceptable salt thereof having an excellent collagen-synthesis inhibition activity. A biaryl derivative having a structure represented by the following General Formula (I) or a pharmacologically acceptable salt thereof: n nwherein n R 1 represents a C 6 -C 10 aryl group which is substituted with one to three group(s) each independently selected from the group consisting of a group defined by formula R-L-, a di-(C 1 -C 6 alkyl)amino group, a di-(C 1 -C 6 alkyl)aminosulfonyl group, a hydroxyaminocarbonyl group, and a halogen atom, and so on; R represents a C 1 -C 6 alkyl group, and so on; L represents a sulfonyl group, an aminosulfonyl group, or a sulfonylamino group, and so on; R 2 represents a hydrogen atom, and so on; A represents a group defined by formula (II), (III), or (IV); R 3 represents a C 1 -C 6 alkyl group, and so on; and R 4 represents a C 1 -C 6 alkyl group, and so on.

专利号:US-9695191-B2
优先权日:2009-08-05
标题 :Conformationally constrained, fully synthetic macrocyclic compounds
发明人:OBRECHT DANIEL; ERMERT PHILIPP; OUMOUCH SAID; LACH FRANCK; LUTHER ANATOL; MARX KARSTEN; MÖHLE KERSTIN
权利人:OBRECHT DANIEL; ERMERT PHILIPP; OUMOUCH SAID; LACH FRANCK; LUTHER ANATOL; MARX KARSTEN; MÖHLE KERSTIN; POLYPHOR AG
摘要:Conformationally restricted, spatially defined 12-30 membered macrocyclic ring systems of type (I) are constituted by three distinct building blocks: an aromatic template a, a conformation modulator b and a spacer moiety c as detailed in the description and the claims. Macrocycles of type (I) are readily manufactured by parallel synthesis or combinatorial chemistry. They are designed to interact with specific biological targets. In particular, they show agonistic or antagonistic activity on the motilin receptor (MR receptor), on the serotonin receptor of subtype 5-HT 2B (5-HT 2B receptor), and on the prostaglandin F2•receptor (FP receptor). They are thus potentially useful for the treatment of hypomotility disorders of the gastrointestinal tract such as diabetic gastroparesis and constipation type irritable bowl syndrome; of CNS related diseases like migraine, schizophrenia, psychosis or depression; of ocular hypertension such as associated with glaucoma and preterm labour.

专利号:US-2010117066-A1
优先权日:2007-04-28
标题:Organic Semiconductors
发明人:HEENEY MARTIN; ZHANG WEINMIN; MCCULLOOCH IAIN
权利人:MERCK PATENT GMBH
摘要:The invention relates to novel substituted dibenzo[d,d′]benzo[1,2-b;4,5-b′]dithiophenes (DBBDT), to methods of their synthesis, to organic semiconducting materials, formulations and layers comprising them, and to electronic devices, like organic field effect transistors (OFETs), comprising them.
杭州和素化学技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hexochem.com
企业联系电话:15382311009👤
📞杭州和素化学技术有限公司 ⚠️参考联系方式
联系人:和素
电话:15382311009
手机:15382311009

邮箱:sales@hexochem.com
通信地址: 杭州市经济及开发区1号大街101号
邮编: 310018
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:杭州市经济及开发区1号大街101号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
浙江扬帆新材料股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.shoufu.cn
企业联系电话:0571-88902507;0571-88902517;0571-88902509👤
📞浙江扬帆新材料股份有限公司 ⚠️参考联系方式
联系人:唐小姐
电话:0571-88902507;0571-88902517;0571-88902509

传真:0571-88902500
邮箱:shoufu@shoufuchem.com
通信地址: 浙江省杭州市滨江区信诚路31号扬帆创业大厦
邮编: 310051
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省杭州市滨江区信诚路31号扬帆创业大厦
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
杭州优联医药化工公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.unipharma-chem.com
企业联系电话:0571-85803833;56766020👤
📞杭州优联医药化工公司 ⚠️参考联系方式
联系人:顾元伟
电话:0571-85803833;56766020

传真:0571-85803855
邮箱:info@unipharma-chem.com
通信地址: 浙江省杭州市朝晖路203号深蓝广场办公楼1109室
邮编: 310010
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省杭州市朝晖路203号深蓝广场办公楼1109室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Davies, G. H. M.; Wisniewski, S. R., Science of Synthesis Knowledge Updates, (2021) 2, 194.
摘要:Yoshikai, N.; Rayner, C. M.; Graham, M. A., Science of Synthesis Knowledge Updates, (2020) 2, 94.
摘要:Yoshikai, N.; Rayner, C. M.; Graham, M. A., Science of Synthesis Knowledge Updates, (2020) 2, 121.
摘要:Sawamura, M.; Shimizu, Y., Science of Synthesis: Knowledge Updates, (2024) 2, 212.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知